ERNA vs J · P/E 0.0, rev $582.0K vs P/E 36, $14.40B cap
Eterna Therapeutics Inc (ERNA) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
J does not have a complete income-statement cache yet.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the ERNA and J stock pages for the full models.
Not investment advice.